Healthcare provider profile · identity verified

Aleksandra Avery, MD

Internal Medicine · GARNER, NC · NPI 1992939409

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	304	97
Rosuvastatin Calcium	Rosuvastatin Calcium	274	76
Amlodipine Besylate	Amlodipine Besylate	263	89
Levothyroxine Sodium	Levothyroxine Sodium	201	53
Omeprazole	Omeprazole	171	55
Losartan Potassium	Losartan Potassium	141	47
Lisinopril	Lisinopril	132	43
Metformin Hcl Er	Metformin Hcl	127	33
Hydrochlorothiazide	Hydrochlorothiazide	123	32
Trazodone Hcl	Trazodone Hcl	115	28
Metoprolol Succinate	Metoprolol Succinate	102	32
Pantoprazole Sodium	Pantoprazole Sodium	90	32
Gabapentin	Gabapentin	87	37
Escitalopram Oxalate	Escitalopram Oxalate	82	23
Ozempic	Semaglutide	69	13
Simvastatin	Simvastatin	69	22
Furosemide	Furosemide	68	24
Valsartan	Valsartan	66	20
Pravastatin Sodium	Pravastatin Sodium	65	22
Tamsulosin Hcl	Tamsulosin Hcl	62	19
Metformin Hcl	Metformin Hcl	61	17
Carvedilol	Carvedilol	60	18
Eliquis	Apixaban	60	18
Ezetimibe	Ezetimibe	60	17
Alendronate Sodium	Alendronate Sodium	58	21
Sertraline Hcl	Sertraline Hcl	54	17
Bupropion Xl	Bupropion Hcl	52	suppressed
Montelukast Sodium	Montelukast Sodium	52	17
Fluticasone Propionate	Fluticasone Propionate	51	22
Allopurinol	Allopurinol	47	12
Mounjaro	Tirzepatide	47	suppressed
Spironolactone	Spironolactone	46	17
Jardiance	Empagliflozin	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Potassium Chloride	Potassium Chloride	41	18
Mirtazapine	Mirtazapine	40	13
Duloxetine Hcl	Duloxetine Hcl	39	16
Synthroid	Levothyroxine Sodium	39	11
Finasteride	Finasteride	38	11
Irbesartan	Irbesartan	37	11
Tramadol Hcl	Tramadol Hcl	37	11
Donepezil Hcl	Donepezil Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	19
Meloxicam	Meloxicam	32	15
Alprazolam	Alprazolam	31	suppressed
Cephalexin	Cephalexin	31	14
Myrbetriq	Mirabegron	31	suppressed
Famotidine	Famotidine	30	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Lorazepam	Lorazepam	29	11
Benazepril Hcl	Benazepril Hcl	28	suppressed
Celecoxib	Celecoxib	28	13
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Estradiol	Estradiol	25	16
Atenolol	Atenolol	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Ondansetron Odt	Ondansetron	21	12
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Azelastine Hcl	Azelastine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Mupirocin	Mupirocin	18	15
Prednisone	Prednisone	18	11
Calcitriol	Calcitriol	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nystatin	Nystatin	17	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Movantik	Naloxegol Oxalate	16	suppressed
Naproxen	Naproxen	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Amoxicillin	Amoxicillin	14	12
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Azithromycin	Azithromycin	11	11
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Torsemide	Torsemide	11	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error